Trademark Overview
On Friday, November 19, 2004, a trademark application was filed for ARRADX with the United States Patent and Trademark Office. The USPTO has given the ARRADX trademark a serial number of 78520404. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 23, 2006. This trademark is owned by ArraDx Limited by change of name from Arragen Limited. The ARRADX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; biochemical preparations for use in diagnosis of cancer; biochemical preparations for diagnostic use; diagnostic preparations for medical purposes; diagnostic products for medical purposes; diagnostic tools; cancer diagnostic preparations, products and tools; microarray based diagnostic tools; microarray based diagnostic tools for cancer diagnosis; clinical diagnostics for medical use; agents of biological origin for use in the diagnosis of disease and cancer; diagnostic kits; pharmaceutical preparations; biochemical preparations for diagnostic use; diagnostic preparations for medical purposes; diagnostic products for medical purposes; diagnostic tools; microarray based diagnostic tools; clinical diagnostics for medical use; agents of biological origin for use in the diagnosis of diseases
medical apparatus and instruments; diagnostic apparatus for medical purposes; apparatus for medical diagnosis; diagnostic products for medical purposes; diagnostic tools; cancer diagnostic products and tools; microarray based diagnostic tools; microarray based diagnostic tools for cancer diagnosis clinical diagnostics for medica; use; agents of biological origin for use in the diagnosis of disease and cancer; diagnostic kits; and parts therefor
biological research, development and testing; biotechnology; biotechnology research, development and testing; bioinformatics; research and development of diagnotic tools; research and development of diagnotic tools for cancer and the cancer market; development of microarray based diagnostic tools; development and clinical validation of diagnostic products; development and clinical validation of cancer diagnostic products; microarray research; microarray services for academic institutions, and for the biotechnology and pharmaceutical industries; design and conduct for experiments; data analysis services; microarray data analysis services; statistical analysis; analysis of microarray; infromation services for facilitating and promoting the gathering, evaluations and dissemination of information relating to clinical trials and/or the efficacy and effects of various medical treatments; information services for facilitating and promoting the gathering, evaluation and dissemination of inform...
